CRWCranewareCRW info
-info-24h
Global rank
Market cap$0
Change 7d-
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$174.02M
Earnings$0
Dividend yield-
Main Sector
Healthcare

Craneware (CRW) Stock Overview

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers appeal, professional, and pharmacy professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

CRW Stock Information

Symbol
CRW
Address
1 TanfieldEdinburgh, EH3 5DAUnited Kingdom
Founded
-
Trading hours
8:00 AM - 4:30 PM GMT
Website
https://www.thecranewaregroup.com
Country
🇬🇧 United Kingdom
Phone Number
44 13 1550 3100

Craneware (CRW) Price Chart

-
Value:-

Craneware Overview: Key Details and Summary

Stock data
2023
Change
Shares Outstanding
35.15M
0.10%
Employees
734.00
N/A
Shareholder Equity
327.84M
-1.56%
Growth
2023
Change
Return on Equity
0.0282
N/A
Earnings
2023
Change
Revenue
$174.02M
N/A
Gross Margin
0.853
N/A
Operating Margin
0.0986
N/A
Net income margin
0.0531
N/A
Financial Strength
2023
Change
Total Assets
$576.98M
N/A
Total Debt
$86.69M
N/A
Cash on Hand
$78.54M
N/A
Debt to Equity
0.7599
8.64%
Cash to Debt
0.9060
121.94%
Current Ratio
0.8947
-20.61%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org